neoplasm
• at 12 weeks following doxycycline treatment, mice develop lung adenocarcinomas
• however, withdrawal of doxycycline or treatment with NVP-BEZ235 leads to tumor regression
|
respiratory system
• at 12 weeks following doxycycline treatment, mice develop lung adenocarcinomas
• however, withdrawal of doxycycline or treatment with NVP-BEZ235 leads to tumor regression
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lung cancer | DOID:1324 |
OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210 |
J:142254 |